从三项临床试验的结果看慢性冠心病药物治疗的新动态
New trends in the pharmaceutical treatment of chronic coronary heart disease (no abstract)
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2005年第7期663-665,共3页
Chinese Journal of Cardiology
参考文献12
-
1Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patient s with chronic stable angina-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation, 2003, 107:149-158.
-
2Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet, 2004, 364:849-857.
-
3Nissen SE, Tuzcy EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial. JAMA, 2004, 292:2217-2226.
-
4The PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med, 2004, 351:2058-2068.
-
5Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis, 2004, 15(Suppl 1):S1-S4.
-
6Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA, 1995, 274:620-625.
-
7Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation, 1995, 92:1326-1331.
-
8The Task Force of the European Society of Cardiology. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J, 1997, 18:394-413.
-
9The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med, 2000, 342:145-153.
-
10The European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet, 2003, 362:782-788.
-
1李晓莉,李雪云.阿托伐他汀联合曲美他嗪治疗慢性冠心病的临床效果研究[J].武警后勤学院学报（医学版）,2016,25(9):714-716. 被引量：8
-
2秦永彦.二尖瓣—室间隔夹角对左心功能的判断价值(附107例分析)[J].山东医药,1990,30(10):8-9.
-
3浦寿月.慢性冠心病的临床诊断与鉴别诊断[J].中华内科杂志,1995,34(1):61-63. 被引量：6
-
4张奇志,王言森,吕舒仪,魏明芬,孟海燕.冠心病患者FgBβm RNA表达及蛋白质水平变化的临床意义[J].山东医药,2004,44(25):41-42.
-
5时文英,时文春.慢性冠心病患者24小时心率变异性分析的研究[J].中华临床医药杂志（北京）,2002,3(19):30-30.
-
6何秉贤.慢性冠心病的现代处理[J].中国处方药,2006(7):27-29.
-
7鞠华敏,曲迎军,岳善峰.常规静息心电图ST—T改变与慢性冠心病冠脉病变及心功能的相关性研究[J].国际医药卫生导报,2016,22(7):944-946. 被引量：8
-
8司长风.同型半胱氨酸与冠心病冠脉狭窄程度的相关性研究[J].世界最新医学信息文摘,2013,13(16):142-143.
-
9双心诊疗亟待突破 传统中药异军突起——众专家呼吁关注冠心病的中西医结合治疗（二）[J].中国心血管病研究,2013,11(3):202-202.
-
10何秉贤.要做介入治疗的慢性冠心病[J].老年健康,2006(8):9-9.
